Bifunctional compounds capable of inducing degradation of polo-like kinase1

CA3328371A1Undetermined Publication Date: 2025-11-06CROSSFIRE ONCOLOGY BV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3328371
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-04-29
Filing Date
2025-04-29
Publication Date
2025-11-06
Patent Text Reader

Abstract

The present invention relates to bifunctional compounds capable of inducing degradation of Polo- like kinase 1 (PLK1) via ubiquitin proteasome pathway. More specifically, the invention relates to bifunctional compounds and conjugates derived thereof, along with processes to prepare the compounds or conjugates, uses thereof and methods for treating diseases through modulation of Polo-like kinase 1 (PLK1). Specifically, the invention relates to the use of the bifunctional compounds or conjugates in the treatment of cancer.
Need to check novelty before this filing date? Find Prior Art